On June 21, 2014, Biogen Idec Inc (NASDAQ:BIIB), and AbbVie are planning to file forms with regulatory agencies to further develop DAC HYP. They will release more detailed DECIDE results at upcoming medical conferences. Analysts mean target price for Biogen Idec Inc. (NASDAQ:BIIB) is $348.64 and On Friday shares its shares opened at $313.85 and closed at $319.59.Biogen Idec Inc. (NASDAQ:BIIB) quarterly revenue growth is 50.50% while quarterly earnings growth is 12.80%. Biogen Idec Inc (NASDAQ:BIIB), net profit margin is 25.00% and weekly performance is 3.10%. On last trading day company shares ended up $319.59. Analysts mean target price for the company is $348.64. Biogen Idec Inc (NASDAQ:BIIB), distance from 50-day simple moving average (SMA50) is 6.83%.
Gabelli initiated coverage on shares of FMC Technologies, Inc. (NYSE:FTI), in a research note released on Thursday morning. The firm issued a hold rating and a $61.00 target price on the stock. FMC Technologies, Inc. (NYSE:FTI), advanced 2.55% in last trading session and ended the day on $61.50. FTI, Gross Margin is 22.50% and its return on assets is 8.30%. FMC Technologies, Inc. (NYSE:FTI), quarterly performance is 17.05%.
Cameron International Corporation (NYSE:CAM), SVP James E. Wright unloaded 75,265 shares of the company’s stock on the open market in a transaction dated Monday, June 9th. The stock was sold at an average price of $65.50, for a total value of $4,929,857.50. Following the completion of the sale, the senior vice president now directly owns 58,158 shares in the company, valued at approximately $3,809,349. Cameron International Corporation (NYSE:CAM), shares moved up 2.41% in last trading session and was closed at $67.60, while trading in range of $66.18 – 67.60. Cameron International Corporation (NYSE:CAM), year to date (YTD) performance is 13.56%.
Molson Coors Brewing Company (NYSE:TAP), was upgraded by stock analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating in a report issued on Friday. The analysts noted that the move was a valuation call. Molson Coors Brewing Company (NYSE:TAP), ended the last trading day at $74.86. Company weekly volatility is calculated as 1.48% and price to cash ratio as 41.02. Molson Coors Brewing Company (NYSE:TAP), showed a positive weekly performance of 5.10%.
On June 19, 2014, Valeant Pharmaceuticals Inc said on Wednesday it began an exchange offer for Botox maker Allergan, Inc. (NYSE:AGN), taking its hostile $50.8 billion bid directly to shareholders. Allergan, Inc. (NYSE:AGN), net profit margin is 18.50% and weekly performance is 2.18%. On last trading day company shares ended up $165.32. Analysts mean target price for the company is $187.60. Allergan, Inc. (NYSE:AGN), distance from 50-day simple moving average (SMA50) is 4.62%.